Company Filing History:
Years Active: 2023-2025
Title: Paul Ken Kodama: Innovator in Cell Surface Glycosylation
Introduction
Paul Ken Kodama is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of cell surface glycosylation, holding 2 patents that focus on innovative methods for assessing and evaluating cell compositions.
Latest Patents
Kodama's latest patents include methods for assessing cell surface glycosylation. These methods provide a way to assess a sample of released surface glycans, such as N-glycans, and determine the presence, absence, or level of glycans in the sample. Additionally, he has developed methods for assaying and evaluating a cell composition by analyzing the cell surface glycan profile and comparing it to a reference sample. His work also includes methods for manufacturing and culturing a plurality of cell compositions that exhibit consistent surface glycan expression with low variability.
Career Highlights
Paul Ken Kodama is currently associated with Juno Therapeutics GmbH, where he continues to advance research in his field. His expertise in glycosylation has positioned him as a key figure in the development of innovative solutions for cell composition analysis.
Collaborations
Kodama collaborates with notable colleagues, including Tom Kowski and Kenneth Mayo Prentice, who contribute to the research and development efforts at Juno Therapeutics GmbH.
Conclusion
Paul Ken Kodama's work in cell surface glycosylation represents a significant advancement in biotechnology. His innovative patents and collaborations highlight his commitment to improving cell composition analysis and manufacturing processes.